The Complete Wegovy vs Mounjaro Comparison Guide
What Is Better Wegovy or Mounjaro: Understanding the Key Differences
When evaluating what is better wegovy or mounjaro, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety. Mounjaro contains tirzepatide, which works as a dual agonist targeting both GIP and GLP-1 receptors, potentially offering enhanced metabolic benefits through this dual pathway approach. Both prescription-only medicines require clinical assessment and ongoing medical supervision.
The dosing schedules also differ significantly between these treatments. Wegovy follows a five-step escalation from 0.25mg to 2.4mg maintenance dose over 16 weeks, whilst Mounjaro uses six doses ranging from 2.5mg up to 15mg over a similar timeframe. Your prescriber will consider your medical history, current medications, and individual response to determine which treatment pathway may be most appropriate for your circumstances.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
Understanding the financial commitment helps answer what is better wegovy or mounjaro from a practical perspective. Wegovy pricing at EverydayMeds starts with 0.25mg at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to maintenance dose 2.4mg at £209.99. New customers can apply discount code FIRST40 at checkout, while returning customers use DOSE25. Our GPhC-registered pharmacy (#9012878) ensures all treatments meet strict UK quality standards.
We offer convenient bundle options to support your treatment journey, including the Intro Trio (0.25mg, 0.5mg & 1mg) for £299.99 and Ultimate Stability Trio (three 2.4mg pens) for £649.99. These bundles provide treatment continuity and reduce the need for frequent reordering. Both Wegovy and Mounjaro are available through our streamlined ordering system, allowing your prescriber to switch between treatments if clinically appropriate during your weight management programme.
Clinical Evidence: How Wegovy and Mounjaro Compare
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved average weight loss of approximately 15% at 68 weeks in STEP 1, compared to 2.4% with placebo. The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events among participants. These results represent outcomes from controlled clinical trials and individual results may vary significantly.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, though direct head-to-head comparisons between semaglutide and tirzepatide use different study populations and endpoints, making percentage comparisons inappropriate. Both treatments require prescription assessment and ongoing medical monitoring. Your prescriber can discuss the specific evidence relevant to your health profile when determining what is better wegovy or mounjaro for your individual circumstances.
How Wegovy Works for Weight Management
Wegovy functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1, a hormone naturally produced in your intestines. This mechanism helps reduce appetite by acting on brain centres that control hunger and satiety, potentially leading to reduced food intake during meals. The treatment may also slow gastric emptying, helping you feel fuller for longer periods after eating. Clinical studies suggest Wegovy can reduce food cravings, particularly for high-calorie foods, though individual responses vary considerably. The once-weekly injection schedule using the FlexTouch pen system provides consistent medication levels throughout the week, supporting steady appetite regulation when combined with lifestyle modifications.
Your EverydayMeds Ordering Process
Accessing either Wegovy or Mounjaro through EverydayMeds begins with our three-minute online clinical assessment, covering your medical history, current medications, and weight management goals. Our qualified prescribers review your assessment within three working days (or 24 hours with express service) to determine treatment suitability and answer what is better wegovy or mounjaro for your specific needs. Once approved, your prescription-only medicine ships via next-day delivery using cold-chain, temperature-controlled packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures all treatments meet MHRA standards and include comprehensive patient information leaflets. You'll receive ongoing support throughout your treatment journey, with easy reordering and clinical guidance available when needed.
Storage and Practical Considerations
Storage requirements represent a practical advantage when considering what is better wegovy or mounjaro for your lifestyle. Wegovy maintains stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both treatments require refrigerated storage at 2-8°C before first use, but Wegovy's extended room temperature stability offers greater flexibility for travel and daily routines. The FlexTouch pen system delivers precise dosing with a simple injection mechanism, and both treatments follow structured dose escalation protocols to minimise side effects. Your prescriber will provide detailed injection technique guidance and storage instructions to optimise treatment effectiveness and safety throughout your weight management programme.
Mechanism Comparison: Single vs Dual Receptor Action
The fundamental question of what is better wegovy or mounjaro often centres on their different receptor targeting approaches. Wegovy's semaglutide specifically targets GLP-1 receptors, providing focused appetite regulation and proven cardiovascular benefits demonstrated in the SELECT trial. This targeted approach has extensive clinical experience and established safety profiles across diverse patient populations.
Mounjaro's tirzepatide offers dual receptor activation, targeting both GIP and GLP-1 pathways simultaneously. This dual mechanism may provide enhanced metabolic effects through complementary pathways, though individual responses vary significantly. Both treatments require careful medical supervision and lifestyle modifications to achieve optimal outcomes, making prescriber guidance essential for treatment selection.
Making Your Treatment Decision with EverydayMeds
Rather than definitively answering what is better wegovy or mounjaro, our approach focuses on individualised treatment selection based on your medical profile, lifestyle factors, and treatment goals. Both treatments are available through our streamlined service, allowing flexibility if your prescriber recommends switching between options during your weight management journey. Our clinical team provides ongoing support, monitoring treatment response and adjusting approaches as needed. Apply discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout, and begin your assessment at https://everydaymeds.co.uk/collections/weight-loss. Your weight management success depends on the right treatment match, comprehensive support, and sustained lifestyle modifications working together effectively.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
